Endospan Gets CE Mark for Horizon Stent Graft System

Endospan received European approval to market its Horizon stent graft system for treating abdominal aortic aneurysms.

The company said it is now seeking approval to market its Nexus stent graft system for treating aortic arch disease.

The low-profile Horizon platform can be used to shorten and simplify endovascular aneurysm repair procedures.